Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CMKLR1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CMKLR1 is a concept in neurodegeneration research. Key relationships include: regulates, interacts with, activates. Associated with ALS, Aging, Als. Connected to 84 entities in the SciDEX knowledge graph.
| Name | CMKLR1 |
| Key Genes/Proteins | IL33, GPR32 |
| Related Diseases | pro-inflammatory state, male hypogonadism |
| Related Pathways | glycolysis, type 2 innate immunity |
Knowledge base pages for this entity
graph TD
CMKLR1["CMKLR1"]
CMKLR1 -->|"activates"| Cancer["Cancer"]
CMKLR1 -->|"activates"| Aging["Aging"]
CMKLR1 -->|"activates"| Obesity["Obesity"]
CMKLR1 -->|"activates"| Ischemia["Ischemia"]
CMKLR1 -->|"activates"| Ms["Ms"]
CMKLR1 -->|"interacts"| Alzheimer["Alzheimer"]
CMKLR1 -->|"interacts"| Als["Als"]
Chemerin["Chemerin"] -->|"binds"| CMKLR1
h_470ff83e["h-470ff83e"] -->|"targets"| CMKLR1
CD47["CD47"] -->|"interacts"| CMKLR1
TLR2["TLR2"] -->|"interacts"| CMKLR1
CD36["CD36"] -->|"interacts"| CMKLR1
PINK1["PINK1"] -->|"activates"| CMKLR1
PARKIN["PARKIN"] -->|"activates"| CMKLR1
RAGE["RAGE"] -->|"activates"| CMKLR1
CD14["CD14"] -->|"interacts"| CMKLR1| Target | Relation | Type | Str |
|---|---|---|---|
| testicular macrophages | modulates | cell_type | 0.95 |
| thermogenesis | inhibits | process | 0.90 |
| glycolysis | mediates | pathway | 0.90 |
| pro-inflammatory state | promotes | phenotype | 0.90 |
| immunometabolism | modulates | process | 0.90 |
| autophagy | modulates | process | 0.85 |
| IL33 | regulates | gene | 0.85 |
| type 2 innate immunity | suppresses | pathway | 0.85 |
| male hypogonadism | therapeutic_target | disease | 0.80 |
| MICROGLIA | interacts_with | cell_type | 0.80 |
| GPR32 | encodes | protein | 0.80 |
| microglia | activates | cell_type | 0.70 |
| microglia | regulates | cell_type | 0.70 |
| Cancer | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Obesity | activates | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Alzheimer | interacts_with | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| ALS | interacts_with | disease | 0.65 |
| PARKIN | activates | gene | 0.60 |
| PINK1 | activates | gene | 0.60 |
| RAGE | activates | gene | 0.60 |
| TLR4 | interacts_with | gene | 0.60 |
| CD14 | interacts_with | gene | 0.60 |
| P62 | activates | gene | 0.60 |
| TLR2 | interacts_with | gene | 0.60 |
| TLR2 | regulates | gene | 0.60 |
| TLR4 | regulates | gene | 0.60 |
| neurodegeneration | implicated_in | disease | 0.60 |
| CD36 | interacts_with | gene | 0.60 |
| CD47 | interacts_with | gene | 0.60 |
| P62 | regulates | entity | 0.60 |
| PARKIN | regulates | entity | 0.60 |
| PINK1 | regulates | entity | 0.60 |
| Rb | activates | protein | 0.60 |
| Rb | interacts_with | protein | 0.60 |
| obesity | activates | disease | 0.60 |
| obesity | inhibits | disease | 0.60 |
| obesity | regulates | disease | 0.60 |
| obesity | treats | disease | 0.60 |
| mitochondrial dynamics | participates_in | pathway | 0.60 |
| RAGE | regulates | gene | 0.60 |
| GPR109A | associated_with | gene | 0.60 |
| purinergic receptor | associated_with | receptor | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| P12C5 | targets | drug | 0.95 |
| CD206LoMHCIIHi macrophage subset | expressed_in | cell_type | 0.90 |
| h-470ff83e | targets_gene | hypothesis | 0.90 |
| h-470ff83e | targets | hypothesis | 0.80 |
| CD47 | interacts_with | gene | 0.60 |
| TLR2 | interacts_with | gene | 0.60 |
| CD36 | interacts_with | gene | 0.60 |
| PINK1 | activates | gene | 0.60 |
| PARKIN | activates | gene | 0.60 |
| RAGE | activates | gene | 0.60 |
| CD14 | interacts_with | gene | 0.60 |
| CD14 | regulates | gene | 0.60 |
| CD36 | regulates | gene | 0.60 |
| CD47 | regulates | gene | 0.60 |
| P62 | activates | gene | 0.60 |
| TLR4 | interacts_with | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| OXIDATIVE STRESS | regulates | gene | 0.60 |
| MITOPHAGY | regulates | gene | 0.60 |
| AUTOPHAGY | regulates | gene | 0.60 |
| MICROGLIA | regulates | gene | 0.60 |
| PHAGOCYTOSIS | interacts_with | gene | 0.60 |
| AMYLOID | interacts_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | interacts_with | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| ALZHEIMER | interacts_with | gene | 0.60 |
| AGING | activates | gene | 0.60 |
| PAD4 | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| APOPTOSIS | therapeutic_target | gene | 0.60 |
| IL-33 | activates | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| OBESITY | activates | disease | 0.50 |
| OBESITY | regulates | disease | 0.50 |
| microglia | activates | cell_type | 0.50 |
| Autophagy | activates | process | 0.50 |
| oxidative stress | activates | phenotype | 0.50 |
| NEURONS | activates | concept | 0.50 |
| microglia | regulates | cell_type | 0.50 |
| Autophagy | regulates | process | 0.50 |
| oxidative stress | regulates | phenotype | 0.50 |
| Mitochondrial Function | regulates | pathway | 0.50 |
| microglia | expressed_in | cell_type | 0.50 |
| Autophagy | expressed_in | process | 0.50 |
| apoptosis | expressed_in | process | 0.50 |
| oxidative stress | expressed_in | phenotype | 0.50 |
| mitophagy | activates | pathway | 0.50 |
| microglia | inhibits | cell_type | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Microglial Efferocytosis Enhancement via GPR32 Superagonists | 0.483 | neurodegeneration | Neuroinflammation resolution mechanisms |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.552
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| PAD4 promotes macrophage migration to aggravate tubulointerstitial injury in dia [PMID:41054305] | Xiong Y, Li R, Chen X, Peng C, Zeng Q, Z | Mol Ther | 2026 | 1 |
| Chemerin-CMKLR1 differentially mediated OGD/R-induced mitochondrial dysfunction, [PMID:41151300] | Long PY, Tang Z, Cai N, Yan ZQ, Gao X, W | Biomed Pharmacother | 2025 | 1 |
| The chemerin-CMKLR1 axis limits thermogenesis by controlling a beige adipocyte/I [PMID:34330814] | Lin Y, Xiao L, Cai Q, Zhu C, Li S, Li B, | Sci Immunol | 2021 | 1 |
| Microglial Aβ receptors in Alzheimer's disease. [PMID:25149075] | Yu Y, Ye RD | Cell Mol Neurobiol | 2015 | 1 |
| Molecular Signaling and Biased Agonism of the CHEMR23 Receptor: Implications for [PMID:41486998] | ["Neprelyuk O", "Romanenko I", "Irza O", | Current protein & peptide scie | 2026 | 0 |
| Receptor-Mediated Shuttling of a D-Amino Acid Peptide Achieves High Nanomolar Cy [PMID:41422545] | ["List M", "Beck-Sickinger A"] | Journal of the American Chemic | 2026 | 0 |
| Follicle-dependent differential localization of adipokines in the letrozole-indu [PMID:41857436] | ["Dutta A", "Gurusubramanian G", "Roy V" | Histochemistry and cell biolog | 2026 | 0 |
| Targeting the CMKLR1-Mediated Signaling Rebalances Immunometabolism State in Mid [PMID:41538650] | ["Zhu Z", "Du F", "Liu Y", "Yang J", "Ge | Advanced science (Weinheim, Ba | 2026 | 0 |
| Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary a [PMID:36600187] | ["Sanges S", "Rice L", "Tu L", "Valenzi | Annals of the rheumatic diseas | 2023 | 0 |
| The Chemerin/CMKLR1 Axis Is Involved in the Recruitment of Microglia to Aβ Depos [PMID:36012305] | Chen Y, Liu Z, Gong P, Zhang H, Chen Y, | International journal of molec | 2022 | 0 |
| Chemerin partly mediates tumor-inhibitory effect of all-trans retinoic acid via [PMID:31063220] | Song Y, Yin W, Dan Y, Sheng J, Zeng Y, H | Immunology | 2019 | 0 |
| Chemerin/ChemR23 axis promotes inflammation of glomerular endothelial cells in d [PMID:30784180] | ["Shang J", "Wang L", "Zhang Y", "Zhang | Journal of cellular and molecu | 2019 | 0 |
| Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthri [PMID:27860453] | ["Huang J", "Burston J", "Li L", "Ashraf | Arthritis & rheumatology (Hobo | 2017 | 0 |
| Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, pa [PMID:25713056] | ["Patrick R", "Ames B"] | FASEB journal : official publi | 2015 | 0 |
| The chemerin receptor CMKLR1 is a functional receptor for amyloid-β peptide. [PMID:25079809] | Peng L, Yu Y, Liu J, Li S, He H, Cheng N | Journal of Alzheimer's disease | 2015 | 0 |
| Intestinal inhibition of the Na+/H+ exchanger 3 prevents cardiorenal damage in r [PMID:24622516] | ["Spencer A", "Labonte E", "Rosenbaum D" | Science translational medicine | 2014 | 0 |
| Overexpression of Ras homologous C (RhoC) induces malignant transformation of he [PMID:23382905] | ["Xie S", "Zhu M", "Lv G", "Geng Y", "Ch | PloS one | 2013 | 0 |
| International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coup [PMID:23686350] | ["Davenport A", "Alexander S", "Sharman | Pharmacological reviews | 2013 | 0 |
| Resolvins: natural agonists for resolution of pulmonary inflammation. [PMID:20887750] | Uddin M, Levy BD | Progress in lipid research | 2011 | 0 |